Literature DB >> 11532451

Molecular mechanism for the crystallization of bacteriorhodopsin in lipidic cubic phases.

P Nollert1, H Qiu, M Caffrey, J P Rosenbusch, E M Landau.   

Abstract

Crystals of transmembrane proteins may be grown from detergent solutions or in a matrix of membranous lipid bilayers existing in a liquid crystalline state and forming a cubic phase (in cubo). While crystallization in micellar solutions appears analogous to that for soluble proteins, crystallization in lipidic matrices is poorly understood. As this method was shown to be applicable to several membrane proteins, understanding its mechanism will facilitate a rational design of crystallization, minimizing the laborious screening of a large number of parameters. Using polarization microscopy and low-angle X-ray diffraction, experimental evidence is provided to support a mechanistic model for the in cubo crystallization of bacteriorhodopsin in a lipid matrix. Membrane proteins are thought to reside in curved lipid bilayers, to diffuse into patches of lower curvature and to incorporate into lattices which associate to form highly ordered three-dimensional crystals. Critical testing of this model is necessary to generalize it to other membrane proteins.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11532451     DOI: 10.1016/s0014-5793(01)02747-8

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  27 in total

1.  Protein interactions and membrane geometry.

Authors:  Michael Grabe; John Neu; George Oster; Peter Nollert
Journal:  Biophys J       Date:  2003-02       Impact factor: 4.033

2.  The role of small intraprotein cavities in the catalytic cycle of bacteriorhodopsin.

Authors:  Ran Friedman; Esther Nachliel; Menachem Gutman
Journal:  Biophys J       Date:  2003-08       Impact factor: 4.033

3.  Electron microscopic evidence for nucleation and growth of 3D acetylcholine receptor microcrystals in structured lipid-detergent matrices.

Authors:  Yoav Paas; Jean Cartaud; Michel Recouvreur; Regis Grailhe; Virginie Dufresne; Eva Pebay-Peyroula; Ehud M Landau; Jean-Pierre Changeux
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-17       Impact factor: 11.205

Review 4.  The significance of G protein-coupled receptor crystallography for drug discovery.

Authors:  John A Salon; David T Lodowski; Krzysztof Palczewski
Journal:  Pharmacol Rev       Date:  2011-12       Impact factor: 25.468

Review 5.  Membrane protein crystallization in amphiphile phases: practical and theoretical considerations.

Authors:  Peter Nollert
Journal:  Prog Biophys Mol Biol       Date:  2004-10-07       Impact factor: 3.667

6.  High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor.

Authors:  Vadim Cherezov; Daniel M Rosenbaum; Michael A Hanson; Søren G F Rasmussen; Foon Sun Thian; Tong Sun Kobilka; Hee-Jung Choi; Peter Kuhn; William I Weis; Brian K Kobilka; Raymond C Stevens
Journal:  Science       Date:  2007-10-25       Impact factor: 47.728

7.  LCP-FRAP Assay for Pre-Screening Membrane Proteins for in Meso Crystallization.

Authors:  Vadim Cherezov; Jeffrey Liu; Mark Griffith; Michael A Hanson; Raymond C Stevens
Journal:  Cryst Growth Des       Date:  2008       Impact factor: 4.076

Review 8.  Methodological advances: the unsung heroes of the GPCR structural revolution.

Authors:  Eshan Ghosh; Punita Kumari; Deepika Jaiman; Arun K Shukla
Journal:  Nat Rev Mol Cell Biol       Date:  2015-01-15       Impact factor: 94.444

9.  Development of an Automated High Throughput LCP-FRAP Assay to Guide Membrane Protein Crystallization in Lipid Mesophases.

Authors:  Fei Xu; Wei Liu; Michael A Hanson; Raymond C Stevens; Vadim Cherezov
Journal:  Cryst Growth Des       Date:  2011-04-06       Impact factor: 4.076

10.  Effects of impurities on membrane-protein crystallization in different systems.

Authors:  Christopher A Kors; Ellen Wallace; Douglas R Davies; Liang Li; Philip D Laible; Peter Nollert
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-09-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.